RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

03 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

20 12 2023 07:59:00 提供 Nasdaq GlobeNewswire

Bayer and Recursion Focus Research Collaboration on Oncology

09 11 2023 09:41:30 提供 Nasdaq GlobeNewswire

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

09 11 2023 08:01:00 提供 Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

09 11 2023 07:58:00 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

02 11 2023 08:05:00 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

05 9 2023 16:30:00 提供 Nasdaq GlobeNewswire

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

05 9 2023 07:59:00 提供 Nasdaq GlobeNewswire

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

08 8 2023 08:00:01 提供 Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

08 8 2023 07:58:00 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

01 8 2023 08:30:00 提供 Nasdaq GlobeNewswire

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

26 7 2023 18:58:00 提供 Nasdaq GlobeNewswire

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

12 7 2023 08:30:00 提供 Nasdaq GlobeNewswire

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

26 6 2023 11:48:04 提供 Nasdaq GlobeNewswire

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

13 6 2023 08:00:01 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

01 6 2023 08:30:00 提供 Nasdaq GlobeNewswire

Altitude Lab Relocates to Gateway’s BioHive Hub

25 5 2023 16:00:00 提供 Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

08 5 2023 08:14:39 提供 Nasdaq GlobeNewswire

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

08 5 2023 07:59:00 提供 Nasdaq GlobeNewswire